Based on the Sabra Healthcare REIT Inc stock forecast from 4 analysts, the average analyst target price for Sabra Healthcare REIT Inc is USD 17.71 over the next 12 months. Sabra Healthcare REIT Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Sabra Healthcare REIT Inc is Bullish , which is based on 12 positive signals and 4 negative signals. At the last closing, Sabra Healthcare REIT Inc’s stock price was USD 19.54. Sabra Healthcare REIT Inc’s stock price has changed by +4.10% over the past week, +8.44% over the past month and +37.80% over the last year.
No recent analyst target price found for Sabra Healthcare REIT Inc
No recent average analyst rating found for Sabra Healthcare REIT Inc
Company Overview Sabra Healthcare REIT Inc
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities ("Senior Housing - Leased"), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements ("Senior Housing - Managed"), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2023, Sabra's real estate properties held for investment included 37,606 beds/units, spread across the United States and Canada. Read Less
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities ("Senior Housing - Leased"), (iii) 61 senior housing communities ...Read More
Frequently Asked Questions About Sabra Healthcare REIT Inc (SBRA) Stock
Based on ratings from 4 analysts Sabra Healthcare REIT Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Bullish . The stock has 4 buy, sell and 3 hold ratings.
SBRA stock's dividend yield is 6.19%.
Our analysis grades SBRA stock's dividend yield at F. This means that SBRA stock's dividend yield is above 50% of the stocks in the REIT - Healthcare Facilities sector in the NSD exchange.
Based on this SBRA may be a average dividend stock for its sector.
Based on targets from 4 analysts, the average taret price for SBRA is USD 17.71 over the next 12 months. The maximum analyst target price is USD 20 while the minimum anlayst target price is USD 15.
SBRA stock's Price/Earning ratio is 81.04.
Our analysis grades SBRA stock's Price / Earning ratio at F. This means that SBRA stock's Price/Earning ratio is above 50% of the stocks in the REIT - Healthcare Facilities sector in the NSD exchange.
Based on this SBRA may be fairly valued for its sector
The last closing price of SBRA's stock was USD 19.54.
The most recent market capitalization for SBRA is USD 4.37B.
Based on targets from 4 analysts, the average taret price for SBRA is projected at USD 17.71 over the next 12 months.
This means that SBRA's stock price may go down by -9.34% over the next 12 months.
We can't find any ETFs which contains Sabra Healthcare REIT Inc's stock.
As per our most recent records Sabra Healthcare REIT Inc has 48 Employees.
Sabra Healthcare REIT Inc's registered address is 1781 Flight Way, Tustin, CA, United States, 92782-0539.
You can get more information about it from Sabra Healthcare REIT Inc's website at https://www.sabrahealth.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Underpriced on cashflow basis
The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
High dividend returns
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Frequently Asked Questions About Sabra Healthcare REIT Inc (SBRA) Stock
Based on ratings from 4 analysts Sabra Healthcare REIT Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Bullish . The stock has 4 buy, sell and 3 hold ratings.
SBRA stock's dividend yield is 6.19%.
Our analysis grades SBRA stock's dividend yield at F. This means that SBRA stock's dividend yield is above 50% of the stocks in the REIT - Healthcare Facilities sector in the NSD exchange.
Based on this SBRA may be a average dividend stock for its sector.
Based on targets from 4 analysts, the average taret price for SBRA is USD 17.71 over the next 12 months. The maximum analyst target price is USD 20 while the minimum anlayst target price is USD 15.
SBRA stock's Price/Earning ratio is 81.04.
Our analysis grades SBRA stock's Price / Earning ratio at F. This means that SBRA stock's Price/Earning ratio is above 50% of the stocks in the REIT - Healthcare Facilities sector in the NSD exchange.
Based on this SBRA may be fairly valued for its sector
The last closing price of SBRA's stock was USD 19.54.
The most recent market capitalization for SBRA is USD 4.37B.
Based on targets from 4 analysts, the average taret price for SBRA is projected at USD 17.71 over the next 12 months.
This means that SBRA's stock price may go down by -9.34% over the next 12 months.
We can't find any ETFs which contains Sabra Healthcare REIT Inc's stock.
As per our most recent records Sabra Healthcare REIT Inc has 48 Employees.
Sabra Healthcare REIT Inc's registered address is 1781 Flight Way, Tustin, CA, United States, 92782-0539.
You can get more information about it from Sabra Healthcare REIT Inc's website at https://www.sabrahealth.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SBRA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
